| International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres H Levillain, O Bagni, CM Deroose, A Dieudonné, S Gnesin, OS Grosser, ... European journal of nuclear medicine and molecular imaging 48, 1570-1584, 2021 | 178 | 2021 |
| Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study H Levillain, I Duran Derijckere, L Ameye, T Guiot, A Braat, C Meyer, ... European journal of nuclear medicine and molecular imaging 46, 2270-2279, 2019 | 57 | 2019 |
| 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer H Levillain, I Duran Derijckere, G Marin, T Guiot, M Vouche, N Reynaert, ... EJNMMI research 8, 1-9, 2018 | 53 | 2018 |
| Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic … I Karfis, G Marin, H Levillain, S Drisis, R Muteganya, G Critchi, ... Oncotarget 11 (6), 589, 2020 | 34 | 2020 |
| 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy C Artigas, P Flamen, F Charlier, H Levillain, Z Wimana, R Diamand, ... World journal of urology 37, 1535-1542, 2019 | 29 | 2019 |
| Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a … M Lemaire, V Lucidi, F Bouazza, G Katsanos, B Vanderlinden, H Levillain, ... Hpb 20 (7), 641-648, 2018 | 13 | 2018 |
| Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera R Danieli, M Stella, J Leube, J Tran-Gia, C Marin, CF Uribe, ... EJNMMI physics 10 (1), 64, 2023 | 11 | 2023 |
| Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization … H Levillain, M Burghelea, ID Derijckere, T Guiot, A Gulyban, ... EJNMMI physics 7, 1-19, 2020 | 9 | 2020 |
| Prediction of 177Lu-DOTATATE PRRT outcome using multimodality imaging in patients with gastroenteropancreatic neuroendocrine tumors: results from a prospective phase II LUMEN study M Mileva, G Marin, H Levillain, C Artigas, C Van Bogaert, C Marin, ... Journal of Nuclear Medicine 65 (2), 236-244, 2024 | 8 | 2024 |
| Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation Z Paquier, SL Chao, G Bregni, AV Sanchez, T Guiot, J Dhont, A Gulyban, ... Physica Medica 103, 138-146, 2022 | 7 | 2022 |
| Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values Z Paquier, SL Chao, A Acquisto, C Fenton, T Guiot, J Dhont, H Levillain, ... Biomedical Physics & Engineering Express 8 (6), 065008, 2022 | 7 | 2022 |
| Radiobiology of Combining Radiotherapy with Other Cancer Treatment Modalities V Ahire, N Ahmadi Bidakhvidi, T Boterberg, P Chaudhary, F Chevalier, ... Radiobiology Textbook, 311-386, 2023 | 3 | 2023 |
| Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in … AM Bucalau, B Collette, I Tancredi, M Vouche, M Pezzullo, J Bouziotis, ... European journal of hybrid imaging 7 (1), 12, 2023 | 2 | 2023 |
| The metabolic clinical risk score as a new prognostic model for surgical decision‐making in patients with colorectal liver metastases I Duran Derijckere, H Levillain, A Bohlok, C Mathey, J Nezri, R Muteganya, ... Journal of surgical oncology 121 (2), 350-356, 2020 | 2 | 2020 |
| Implementation of Simplified Protocol for Tumour Dosimetry in Molecular Radiotherapy with Lu-177-DOTATATE R Danieli, G Marin, M Mileva, B Vanderlinden, I Karfis, N Reynaert, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | 1 | 2022 |
| Development of mouse kidney models on a nephron scale and influence of non-uniform activity distribution on preclinical renal dosimetry M Andersson, N Goudin, M Pontoglio, H Levillain, N Reynaert, CS Vargas Journal of Nuclear Medicine 65 (supplement 2), 242090-242090, 2024 | | 2024 |
| Machine learning model using F-18-FDG PET/CT-based biomarkers to support clinical decision making in advanced chemorefractory metastatic colorectal cancer J Dhont, H Levillain, T Guiot, B Vanderlinden, KB Boni, P Flamen, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Tumour Absorbed Dose for Prediction of Anatomical Response to Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Pancreatic Neuroendocrine Tumours (PanNETs) M Mileva, R Danieli, H Levillain, G Marin, C Marin, P Flamen, I Karfis EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Quality Assurance of PET-based Radiomic Features in the Prospective Randomised Multicentre PEPITA-trial Z Paquier, H Levillain, T Guiot, B Vanderlinden, E Woff, A Gulyban, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1), S23-S23, 2022 | | 2022 |
| Tumour dosimetry after Lutetium-177 PSMA Therapy: a new voxel-based approach with time-integration at the volume level R Danieli, C Marin, C Artigas, Q Shagera, B Vanderlinden, N Reynaert, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
